# RCT of Nintedanib in Fibrotic Sarcoidosis

> **NCT06479603** · PHASE4 · RECRUITING · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 120 (estimated)

## Conditions studied

- Sarcoidosis, Pulmonary

## Interventions

- **DRUG:** Nintedanib
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT06479603
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479603, "RCT of Nintedanib in Fibrotic Sarcoidosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06479603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*